Dynavax Technologies
DVAX
DVAX was delisted on the 9th of February, 2026.
215 hedge funds and large institutions have $1.64B invested in Dynavax Technologies in 2023 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 81 increasing their positions, 76 reducing their positions, and 25 closing their positions.
169% more call options, than puts
Call options by funds: $6.3M | Put options by funds: $2.34M
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
31% more capital invested
Capital invested by funds: $1.25B → $1.64B (+$388M)
7% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 76
0% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 25
0% less funds holding
Funds holding: 216 → 215 (-1)
1.21% less ownership
Funds ownership: 100.16% → 98.95% (-1.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$26.8M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
+$19.6M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$12.3M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$11.7M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$6.92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$32.2M |
| 2 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$17.1M |
| 3 |
State Street
Boston,
Massachusetts
|
-$13.2M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$12.5M |
| 5 |
Renaissance Technologies
New York
|
-$7.63M |
DVAX Hedge Fund Activity: Q2 2023 in Review
215 of the 6,371 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q2 2023, worth a combined $1.64B — up 31% from $1.25B a quarter earlier.
Fund positioning in DVAX was balanced in Q2 2023: 25 funds opened new positions, 25 closed out, 81 added to existing stakes and 76 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $26.8M. The largest seller was Bank of America, cutting an estimated $32.2M.
- 215 institutional investors held Dynavax Technologies (DVAX) as of Q2 2023, down from 216 in Q1 2023.
- Funds reported $1.64B of Dynavax Technologies stock for Q2 2023, up 31% quarter-over-quarter.
- 25 funds opened new Dynavax Technologies positions in Q2 2023 and 25 closed out, a net change of 0 holders.
- The largest Dynavax Technologies buyer in Q2 2023 was Citadel Advisors, an estimated $26.8M added.
- The largest Dynavax Technologies seller in Q2 2023 was Bank of America, an estimated $32.2M sold.
Based on aggregated 13F filings for Q2 2023.